Blog

New Canada Research Chair Working on “Smart” Cancer Drugs

  • Jan 25th, 2017
  • Guy Paterson

New Canada Research Chair working on “smart” cancer drugs

From: University of Saskatchewan Communications

Eric Price, a new Canada Research Chair (CRC) in Radiochemistry at the University of Saskatchewan, is leading work on developing a new generation of medical imaging technology and “smart” drugs for cancer treatment.  

Selective in their targeting of cancer, these new drugs hold promise to reduce side effects compared with traditional chemotherapy, said Price, who has been recruited to the U of S chemistry department.

“These new radioactive drugs will be like sniffing dogs,” said Price. “They will be able to select specific cancer cells and kill them, while sparing healthy ones.”

Price’s research will also be applied to addressing the growing problem of bacterial infections that have become resistant to current drug treatments.Price’s work is supported by new radiochemistry labs at the university’s Saskatchewan Centre for Cyclotron Sciences (SCCS). He also plans to use the university’s Canadian Light Source (CLS) synchrotron for research aimed at finding more effective chelators—molecules that bind to radioactive isotopes and allow for more targeted delivery within the body.    

Author

Guy Paterson Co-chair Saskatoon Chamber of Commerce - Health Opportunities Committee

Add A Comments